DownloadHi-Res Photo

Shivani Srivastava, PhD

Postdoctoral Associate

Research & Publications
Biography
Locations

Coauthors

Selected Publications

Catalysis‐Independent ENPP1 Protein Signaling Regulates Mammalian Bone MassZimmerman K, Liu X, von Kroge S, Stabach P, Lester ER, Chu EY, Srivastava S, Somerman MJ, Tommasini SM, Busse B, Schinke T, Carpenter TO, Oheim R, Braddock DT. Catalysis‐Independent ENPP1 Protein Signaling Regulates Mammalian Bone Mass Journal Of Bone And Mineral Research 2022, 37: 1733-1749. PMID: 35773783, PMCID: PMC9709593, DOI: 10.1002/jbmr.4640.
Expression kinetics reveal the self-adaptive role of β cells during the progression of diabetes.Srivastava S, Pandey H, Tripathi YB. Expression kinetics reveal the self-adaptive role of β cells during the progression of diabetes. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2018, 106: 472-482. PMID: 29990835, DOI: 10.1016/j.biopha.2018.06.168.
Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets.Srivastava S, Pandey H, Singh SK, Tripathi YB. Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets. Bioscience Trends 2019, 13: 382-393. PMID: 31597821, DOI: 10.5582/bst.2019.01181.
Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis.Srivastava S, Shree P, Pandey H, Tripathi YB. Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2018, 97: 330-338. PMID: 29091882, DOI: 10.1016/j.biopha.2017.10.071.
GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes.Srivastava S, Pandey H, Singh SK, Tripathi YB. GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes. Advanced Pharmaceutical Bulletin 2019, 9: 325-330. PMID: 31380261, PMCID: PMC6664108, DOI: 10.15171/apb.2019.039.
Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach.Srivastava S, Shree P, Tripathi YB. Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach. Journal Of Diabetes And Metabolic Disorders 2017, 16: 46. PMID: 29201861, PMCID: PMC5697100, DOI: 10.1186/s40200-017-0328-0.
Epigenetic Regulation of Gut Microbial Dysbiosis.Srivastava S, Singh A, Sandeep K, Yadav D. Epigenetic Regulation of Gut Microbial Dysbiosis. Indian Journal Of Microbiology 2021, 1-5. PMID: 33612870, PMCID: PMC7877904, DOI: 10.1007/s12088-021-00920-y.
Immune Modulatory Effects of Ketogenic Diet in Different Disease ConditionsSrivastava, S.; Pawar, V.A.; Tyagi, A.; Sharma, K.P.; Kumar, V.; Shukla, S.K. Immune Modulatory Effects of Ketogenic Diet in Different Disease Conditions. Immuno 2023, 3, 1-15. https://doi.org/10.3390/immuno3010001
Gut Microbiome and Metabolic SyndromeSrivastava S, Aditi P, Yadav D. Gut Microbiome and Metabolic Syndrome. The Metabolic Syndrome: Dietary Supplements and Food Ingredients. 2023.
Beta Cells and DiabetesSrivastava S, Yadav D, Sandeep K, Pandey H, Singh SK, Tripathi YB. Beta Cells and Diabetes. Nutraceuticals and Dietary Supplements: Applications in Health Improvement and Disease Management. 2020 Nov 5:295.

Edit Profile

Shivani Srivastava, PhD

Contact Information

Lab Location

Related Links

Research & Publications

Biography

Locations

Coauthors

Selected Publications